1.38
price up icon0.73%   0.010
after-market アフターアワーズ: 1.38
loading

Compass Therapeutics Inc (CMPX) 最新ニュース

pulisher
Dec 19, 2024

Biliary Tract Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News

Dec 19, 2024
pulisher
Dec 18, 2024

Bioventus (NYSE:BVS) Upgraded to “Neutral” at JPMorgan Chase & Co. - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

Charles Schwab Investment Management Inc. Purchases New Stake in Ferrovial SE (NASDAQ:FER) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

The Manufacturers Life Insurance Company Purchases Shares of 13,221 Design Therapeutics, Inc. (NASDAQ:DSGN) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

Treatment Resistant Depression Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR

Dec 18, 2024
pulisher
Dec 18, 2024

Charles Schwab Investment Management Inc. Purchases 9,268 Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

The Manufacturers Life Insurance Company Invests $75,000 in Atossa Therapeutics, Inc. (NASDAQ:ATOS) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

The Manufacturers Life Insurance Company Buys New Shares in Solid Biosciences Inc. (NASDAQ:SLDB) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

Charles Schwab Investment Management Inc. Grows Stock Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

Dec 18, 2024
pulisher
Dec 16, 2024

Layoff Tracker: Editas Will Cut 60% of Staff - BioSpace

Dec 16, 2024
pulisher
Dec 16, 2024

Short Interest in Compass Therapeutics, Inc. (NASDAQ:CMPX) Increases By 17.9% - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

KalVista Appoints Jeb Ledell as Chief Operating Officer - citybiz

Dec 16, 2024
pulisher
Dec 16, 2024

KalVista Pharmaceuticals Taps Former AVEO Oncology Executive as New COO in Strategic Leadership Move - StockTitan

Dec 16, 2024
pulisher
Dec 14, 2024

Compass Therapeutics, Inc. Announces Executive Changes - Marketscreener.com

Dec 14, 2024
pulisher
Dec 12, 2024

Sirius XM (NASDAQ:SIRI) Appoints Wayne D. Thorsen as Executive Vice President and COO - Defense World

Dec 12, 2024
pulisher
Dec 12, 2024

Capstone Companies Reports Resignation of Directors and Appointment of New CEO - Defense World

Dec 12, 2024
pulisher
Dec 12, 2024

Janus Henderson Group PLC Sells 3,373,056 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - MarketBeat

Dec 12, 2024
pulisher
Dec 12, 2024

Reading International, Inc. Reports Results of 2024 Annual Meeting - Defense World

Dec 12, 2024
pulisher
Dec 12, 2024

Greif, Inc. Revises 2024 Earnings Results Following Error Detection - Defense World

Dec 12, 2024
pulisher
Dec 12, 2024

Plains All American Pipeline Reveals Plans for Investor Event and Updated Presentation Materials - Defense World

Dec 12, 2024
pulisher
Dec 12, 2024

CONMED Corporation Declares Quarterly Cash Dividend - Defense World

Dec 12, 2024
pulisher
Dec 12, 2024

MoneyLion Inc. Announces Merger Agreement with Gen Digital Inc. - Defense World

Dec 12, 2024
pulisher
Dec 11, 2024

Compass Therapeutics names Barry Shin as new CFO By Investing.com - Investing.com Canada

Dec 11, 2024
pulisher
Dec 10, 2024

Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year? - MSN

Dec 10, 2024
pulisher
Dec 10, 2024

Is DXP Enterprises (DXPE) Stock Undervalued Right Now? - Yahoo Finance

Dec 10, 2024
pulisher
Dec 10, 2024

Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR

Dec 10, 2024
pulisher
Dec 10, 2024

Compass (COMP) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance

Dec 10, 2024
pulisher
Dec 10, 2024

Compass Therapeutics Appoints Barry Shin as Chief Financial Officer - citybiz

Dec 10, 2024
pulisher
Dec 10, 2024

Compass Therapeutics names Barry Shin as new CFO - Investing.com India

Dec 10, 2024
pulisher
Dec 10, 2024

Compass Therapeutics Appoints New CFO Amid Strategic Moves - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

Compass Therapeutics Names Barry Shin Chief Financial Officer - MarketWatch

Dec 10, 2024
pulisher
Dec 10, 2024

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - The Manila Times

Dec 10, 2024
pulisher
Dec 09, 2024

Compass Therapeutics: Near-Term Readout, But Beware The High Stakes In Biliary Cancer - Seeking Alpha

Dec 09, 2024
pulisher
Dec 09, 2024

Here is What to Know Beyond Why QUALCOMM Incorporated (QCOM) is a Trending Stock - Yahoo Finance

Dec 09, 2024
pulisher
Dec 07, 2024

Why is Sociedad Química y Minera de Chile S.A. (SQM) Among the Best Lithium and Battery Stocks to Invest In? - Yahoo Finance

Dec 07, 2024
pulisher
Dec 06, 2024

Ways employees can navigate toxic bosses - Yahoo Finance

Dec 06, 2024
pulisher
Dec 04, 2024

Top US Penny Stocks To Watch In December 2024 - Yahoo Finance

Dec 04, 2024
pulisher
Dec 03, 2024

SiriusXM to Present at the UBS Global Media and Communications Conference - Yahoo Finance

Dec 03, 2024
pulisher
Dec 02, 2024

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Dec 02, 2024
pulisher
Dec 02, 2024

Compass Therapeutics to Present at Piper Sandler Healthcare Conference - StockTitan

Dec 02, 2024
pulisher
Nov 28, 2024

Cancer Pain Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - The Globe and Mail

Nov 28, 2024
pulisher
Nov 27, 2024

Celsius Holdings Inc. (CELH) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Nov 27, 2024
pulisher
Nov 25, 2024

Major Depressive Disorder Market to Register Immense Growth by 2034 Owing to a Robust Pipeline | DelveInsight - The Malaysian Reserve

Nov 25, 2024
pulisher
Nov 21, 2024

Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX) - Yahoo Canada Finance

Nov 21, 2024
pulisher
Nov 19, 2024

PD-1 and PD-L1 Inhibitors Market Future Trends and Scope Analysis Report - openPR

Nov 19, 2024
pulisher
Nov 18, 2024

FY2024 EPS Estimates for BCAX Cut by Cantor Fitzgerald - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

Compass Therapeutics (NASDAQ:CMPX) Cut to Market Perform at Leerink Partners - Defense World

Nov 18, 2024
pulisher
Nov 17, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock - MSN

Nov 16, 2024
pulisher
Nov 16, 2024

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious - MSN

Nov 16, 2024
pulisher
Nov 16, 2024

Leerink Partnrs Downgrades Compass Therapeutics (NASDAQ:CMPX) to Hold - MarketBeat

Nov 16, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
大文字化:     |  ボリューム (24 時間):